AusperBio Announces IND Approval from China CDE for HBV ASO AHB-137

SAN FRANCISCO, June 28, 2023 /PRNewswire/ -- AusperBio Therapeutic, Inc. and Ausper Biopharma Co., Ltd. (Together AusperBio), a clinical-stage bio...

Related Keywords

China ,New Zealand ,United States ,Cheng Yong Yang ,Ausper Biopharma Co Ltd ,Prnewswire Ausperbio Therapeutic Inc ,Bio Therapeutic ,Together Ausperbio ,Drug Evaluation ,Investigational New Drug ,Guofeng Cheng ,